- Home>
- Specialty Care>
- HIV/AIDS>
- Top Stories
Top Stories for HIV/AIDS
Top HIV/AIDS Stories of 2007
- HIV/AIDS
- Feature
- Free
A perspective on the year’s most important stories in HIV medicine
- By Paul E. Sax, MD
- December 28, 2007
Top HIV/AIDS Stories of 2006
- HIV/AIDS
- Letter to Readers
- Free
The ACC editors offer their perspective on the year’s most important stories in HIV medicine.
- By Paul E. Sax, MD
- December 29, 2006
New CDC HIV Testing Guidelines for Adults and Adolescents
- HIV/AIDS
- Top Story
- Free
Routine HIV screening should now be offered at all points of care to all individuals aged 13 to 64, regardless of their potential risk for infection.
- By Judith Feinberg, MD
- December 29, 2006
One Pill, Once Daily = Triple Therapy for HIV
- HIV/AIDS
- Top Story
- Free
A single tablet contains efavirenz, tenofovir, and FTC, one of the most effective triple-drug regimens available for treatment-naive patients.
- By Paul E. Sax, MD
- December 29, 2006
Resistance Testing: A New Emphasis on Detecting Transmitted Resistance
- HIV/AIDS
- Top Story
- Free
All HIV-infected patients should undergo genotype testing prior to initiation of antiretroviral therapy.
- By Charles B. Hicks, MD
- December 29, 2006
Standard Triple-Drug Regimens Remain the Best for Initial Therapy
- HIV/AIDS
- Top Story
- Free
Efavirenz-based regimens appear to be particularly effective.
- By Abigail Zuger, MD
- December 29, 2006
Expanded HIV Treatment in Resource-Poor Countries
- HIV/AIDS
- Top Story
- Free
Initial concerns that antiretroviral therapy would be less effective in resource-poor settings 
or that patients there would be less adherent appear to be unfounded.
- By Carlos del Rio, MD
- December 29, 2006
Promising New Options for Treatment-Experienced Patients
- HIV/AIDS
- Top Story
- Free
Even triple-class–experienced patients can achieve virologic suppression with some of the new agents now available.
- By Helmut Albrecht, MD
- December 29, 2006
Discouraging News on Structured Treatment Interruption
- HIV/AIDS
- Top Story
- Free
Structured treatment interruptions that allow CD4 counts to drop below 350 cells/mm3 are unsafe and should not be recommended.
- By Keith Henry, MD
- December 29, 2006
XDR TB: A Growing Public Health Concern
- HIV/AIDS
- Top Story
- Free
Global increases in multidrug-resistant and extensively drug-resistant TB are threatening both TB and HIV treatment programs worldwide and raise concerns about a future epidemic of virtually untreatable TB.
- By Salim S. Abdool Karim, MD, PhD
- December 29, 2006